IL24 and neoplasm: Depletion of neutrophils also abrogates the therapeutic efficacy, despite not statistically significant (Supplementary Fig. 5A–D), demonstrating ZD55-IL-24 can also activate the tumor-infiltrating neutrophils, which help tumor regression as well.